DHS Revises Tiering Assignments Under Chemical-Site Security Measures - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

DHS Revises Tiering Assignments Under Chemical-Site Security Measures


ePT--the Electronic Newsletter of Pharmaceutical Technology

The Department of Homeland Security (DHS) announced it has revised tiering assignments for several chemical facilities covered under DHS’s Chemical Facility Anti-Terrorism Standards (CFATS) program, which requires chemical companies to develop and implement specific security plans for their facilities.

DHS reported that it has communicated with chemical-sector organizations and individually notified certain high-risk facilities of revised tiering assignments that affected a limited number of facilities covered under the CFATS program, according to a DHS statement. DHS uses risk-assessment computer programs to help DHS identify facilities that are high risk. Following a DHS review of the results of one of the risk assessment tools that revealed some apparent anomalies, DHS replaced modeling data in one part of the tool, potentially affecting the tiering assignments for facilities with certain chemical holdings. DHS subsequently re-evaluated the tiering assignments for those facilities and adjusted the tiering in some cases.

DHS reported that none of the affected facilities will receive a higher-risk tier assignment as a result of this re-evaluation; instead many will be assigned to lower risk tiers or no longer be subject to CFATS regulation. To facilitate compliance with the CFATS program, DHS says it continues to offer various assistance tools, including a help desk, Web-based tools and seminars, and on-site visits to all covered facilities.

The Society of Chemical Manufacturers & Affiliates (SOCMA), the US-based trade association representing custom and batch manufacturers, reported on the DHS statement in a SOCMA press release. DHS also had made the announcement at the Chemical Sector Security Summit, which was held in Baltimore earlier this month. The summit is organized by DHS’s Office of Infrastructure Protection as the Chemical Sector-Specific Agency and the Chemical Sector Coordinating Council.

According to the SOCMA release, the DHS changes affected 500 chemical facilities with site vulnerability assessments based on sabotage and release toxic scenarios, not theft and diversion, and the affected facilities represented 10% of all CFATS regulated facilities, The affected facilities were notified about the changes through an electronic letter on June 27.

ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
What role should the US government play in the current Ebola outbreak?
Finance development of drugs to treat/prevent disease.
Oversee medical treatment of patients in the US.
Provide treatment for patients globally.
All of the above.
No government involvement in patient treatment or drug development.
Finance development of drugs to treat/prevent disease.
27%
Oversee medical treatment of patients in the US.
14%
Provide treatment for patients globally.
8%
All of the above.
41%
No government involvement in patient treatment or drug development.
11%
Jim Miller Outsourcing Outlook Jim MillerCMO Industry Thins Out
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerFluorination Remains Key Challenge in API Synthesis
Marilyn E. Morris Guest EditorialMarilyn E. MorrisBolstering Graduate Education and Research Programs
Jill Wechsler Regulatory Watch Jill Wechsler Biopharma Manufacturers Respond to Ebola Crisis
Sean Milmo European Regulatory WatchSean MilmoHarmonizing Marketing Approval of Generic Drugs in Europe
FDA Reorganization to Promote Drug Quality
FDA Readies Quality Metrics Measures
New FDA Team to Spur Modern Drug Manufacturing
From Generics to Supergenerics
CMOs and the Track-and-Trace Race: Are You Engaged Yet?
Source: ePT--the Electronic Newsletter of Pharmaceutical Technology,
Click here